Autogynephilia:The Study Activists Wanted Buried - Dr. Ray Blanchard (#41)
Dr. Ray Blanchard coined the term autogynephilia in 1989 after fifteen years at a gender identity clinic. His typology of male-to-female transsexualism became scientifically influential and politically explosive in equal measure. As Sweden, Finland and the Netherlands reassess what went wrong inside their own gender clinics, this episode asks whether the organised suppression of Blanchard's research contributed to the problem — and what restoring it to the clinical conversation would mean for European practitioners navigating a rapidly shifting landscape.
Dr. Ray Blanchard spent fifteen years working inside a gender identity clinic, observing and classifying the patients who came through its doors. That clinical experience produced one of the most contested concepts in modern sexology: autogynephilia, the erotic arousal a man experiences at the thought or image of himself as a woman. In this episode of Beyond Gender, Blanchard speaks for himself about that research, explaining how it emerged from sustained clinical observation and why he believes it remains indispensable to any honest account of male-to-female gender dysphoria. The framework he developed describes two distinct pathways to male-to-female transsexualism. One is rooted in homosexual attraction — individuals attracted to men who experience gender dysphoria from an early age. The other pathway, driven by autogynephilia, involves a different erotic orientation: a sexual response to the idea of the self as female, distinct from simple cross-dressing and not reducible to attraction to other people. His 1989 paper named and defined this second category, arguing that collapsing the two together obscured clinically important distinctions that mattered for patient care. What makes this episode particularly significant is its subtitle. Blanchard's research is described as a study activists wanted buried, and the episode examines how that burial was attempted. In the years following his publication, organised pressure worked to marginalise his typology, associating it with stigma and challenging its scientific legitimacy. The accusation was that naming autogynephilia as an erotic phenomenon was inherently demeaning. His defenders argued, and continue to argue, that accurate clinical description serves patients better than ideologically motivated silence. The result was a decades-long schism in which an empirically grounded framework was treated as politically impermissible inside the very institutions most responsible for gender medicine. That suppression carries direct consequences for Europe. The Dutch Protocol, developed in Amsterdam and refined across the 1990s, became the international template for paediatric and adult gender medicine worldwide. As that template has since come under sustained scrutiny in Sweden, Finland, Britain and the Netherlands itself, serious questions are being asked about the clinical assumptions that went unchallenged for so long. A research tradition effectively silenced in North America could not easily surface in clinical debate elsewhere, and gender clinics in Germany, France and across Scandinavia operated in an environment where Blanchard's contribution had been written out of mainstream professional discourse. The question at the heart of this episode — whether the medical establishment traded scientific accuracy for political expediency — has a clearly European dimension. Professional guidelines issued by psychiatric and endocrinological associations across the continent, and the training of a generation of clinicians in the Netherlands, Belgium and beyond, all unfolded during the period when Blanchard's work was under its heaviest attack. For European practitioners now navigating revised national guidelines, and for patients seeking honest explanations of what drove their dysphoria, this conversation with the researcher who named and defined autogynephilia is a necessary and long-overdue correction to the record.
